Non-cardiac surgery and antiplatelet therapy following coronary artery stenting

Luckie, M.; Khattar, R. S.; Fraser, D.
August 2009
Heart;Aug2009, Vol. 95 Issue 16, p10
Academic Journal
Coronary artery stenting is increasingly used as a treatment for coronary artery disease. A period of antiplatelet therapy is mandatory following coronary stenting, in order to minimise the risk of stent thrombosis. About 5% of patients who undergo coronary stenting will require non-cardiac surgery within 12 months, and the management of antiplatelet therapy in this setting is complex, requiring a balance between the risks of both operative haemorrhage and stent thrombosis. The available evidence to guide decision-making in the management of antiplatelet therapy in this setting is reviewed.


Related Articles

  • Controversy over cost effectiveness of drug-eluting stents.  // PharmacoEconomics & Outcomes News;2/25/2006, Issue 497, p5 

    Discusses research on the cost effectiveness of drug eluting coronary artery stenting in patients in Great Britain. Reference to a study by A. Bagust et al, published in the January 2006 issue of the "Heart"; Analysis of data from patients who received stent placements; Risk of repeat...

  • Coronary Angioplasty and Stenting in Orthotopic Heart Transplants: A Fruitful Act or a Futile Attempt? Sharifi, Mohsen; Siraj, Yaser; O'Donnell, Jacqueline; Pompili, Vincent J. // Angiology;Oct2000, Vol. 51 Issue 10, p809 

    Reports on the outcome of patients who underwent coronary artery angioplasty and stenting at the late stage of transplantation. Mortality due to allograft coronary artery disease after a year of transplantation; Efficacy of interventions in orthotopic heart transplants; Indications for...

  • Industry is pooling $100M for massive DAPT trial. McCarty, Mark // Medical Device Daily;10/17/2008, Vol. 12 Issue 221, p6 

    The article reports on the launch of a study on the effect of dual antiplatelet therapy (DAPT) on patients getting coronary artery stents in 2008. The study, which is slated to be completed in 2012, will evaluate stent thrombosis and major adverse cardiac and cerebrovascular events. Physician...

  • Ask the Experts. Galli, Annmarie; Palatnik, AnneMarie // Critical Care Nurse;Apr2005, Vol. 25 Issue 2, p88 

    Provides information on arterial and venous sheath removal after percutaneous coronary intervention (PCI). Background on bleeding complications after PCI; Anticoagulation therapies used for bleeding complications; Activated clotting time for removing a femoral sheath; Variation of protocols for...

  • Sirolimus.  // Reactions Weekly;1/26/2008, Issue 1186, p34 

    The article describes the case of a 51-year-old man who developed total stent occlusion with thrombosis after undergoing implantation of a sirolimus-eluting stent. The patient received 300mg of antiplatelet drug clopidogrel before undergoing primary stenting of his left anterior descending...

  • Review gives thumbs up to drug-eluting stents. Pinn, Stephen // British Journal of Hospital Medicine (17508460);Mar2008, Vol. 69 Issue 3, p129 

    The article reports on the conclusion of American researchers on the benefits and risks associated with drug-eluting stents (DES). It concludes that the weight of evidence suggests that DES do more good than harm in patients undergoing percutaneous coronary intervention. Researchers asserted...

  • Impact of avoiding cardiopulmonary bypass for coronary surgery on perioperative cardiac enzyme release and survival Kuduvalli, Manoj; Newall, Nick; Stott, Anthony; Grayson, Antony D.; Fabri, Brian M. // European Journal of Cardio-Thoracic Surgery;May2006, Vol. 29 Issue 5, p729 

    Abstract: Objective: This study examines the association between avoiding the use of cardiopulmonary bypass (CPB) for coronary surgery and postoperative cardiac enzyme (CE) release, and its subsequent impact on survival. Methods: Between January 1999 and September 2002, 3734 consecutive patients...

  • Elective placement of covered stents in native coronary arteries. SØvik, E.; KlØw, N-E.; Brekke, M.; Stavnes, S.; Søvik, E; Kløw, N-E // Acta Radiologica;May2003, Vol. 44 Issue 3, p294 

    Purpose: To study the feasibility of placing a polytetrafluoroethylene (PTFE)-covered stent graft into native coronary arteries and assess the complications and the restenosis rate. Material and Methods: Fifty consecutive patients with stable angina pectoris were...

  • A bridge too far. Gunn, Julian // Heart;Feb2012, Vol. 98 Issue 4, p329 

    Images of left coronary angiogram showing anterior descending artery and myocardial fractional flow reserve (FFR) of patients before during and after stenting of the mid vessel fixed lesion and proximal muscular bridge.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics